CCRB Logo

Trial History Detail on 2012-04-17

CUHK_CCT00157

2008-03-20

Prospective

Nil

Departmental funding from DOVS, CUHK ( for the drug bevacizumab (avastin))

Nil

Nil

Dr. Felix CH Li

Hong Kong Eye Hospital, 147K Argyle Street, Kowloon

27623000

email xil@dr.com

Hong Kong Eye Hospital

Prof. Dennis SC Lam

3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon.

27623134

email dennislam_cu_res@cuhk.edu.hk

Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong

Phaco-trabeculectomy with adjunctive intra-vitreal injection of bevacizumab (Avastin). A preliminary study

Phaco-trabeculectomy with adjunctive intra-vitreal injection of bevacizumab (Avastin). A preliminary study

Nil

Hong Kong

Yes

2008-02-19

Glaucoma

Other

Drug+Procedure

Phaco-Trabeculectomy with intravitreal injection of Bevacizumab (Avastin)

60-90 min

No control or comparative treatment for this study

Inclusion Criteria 1. Age 18 years or above 2. Eyes that undergo phaco-trabeculectomy 3. Patient able and willing to give informed consent to phaco-trabeculectomy with intra-vitreal injection of bevacizumab.

Exclusion criteria 1. Single functional eye 2. Pregnant patients 3. Patients refusing phaco-trabeculectomy or bevacizumab injection 4. Use of anticoagulants or anti-platelet therapy other than aspirin/NSAIDs within 14 days of surgery. 5. Presence of a non-healing wound, ulcer, fracture, or any medical condition associated with bleeding

18

None set

Both Male and Female

Interventional

Non-randomized

Uncontrolled

Open label

Single group

2008-03-25

30

Complete

Intra-ocular pressure

1. Bleb morphology (with photographic record) 2. Visual acuity 3. Number of IOP-lowering medications 4. Corneal clarity and corneal endothelial cell count (by specular microscopy) 5. Posterior capsular opacification 6. Progression in glaucomatous optic neuropathy and visual field loss 7. Any complications from surgery

No

2012-04-17

ChiCTR-TRC-09000716

2010-05-04


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.